Quantumzyme Statistics

Total Valuation

Quantumzyme has a market cap or net worth of 125.46 million. The enterprise value is 125.73 million.

Market Cap	125.46M
Enterprise Value	125.73M

Important Dates

The next estimated earnings date is Tuesday, March 17, 2026.

Earnings Date	Mar 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Quantumzyme has 38.96 million shares outstanding.

Current Share Class	38.96M
Shares Outstanding	38.96M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+10.95%
Owned by Insiders (%)	79.56%
Owned by Institutions (%)	n/a
Float	7.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-255.73
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-684.73
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.00

Current Ratio	0.00
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.81

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	32.37%
Weighted Average Cost of Capital (WACC)	142.32%
Revenue Per Employee	n/a
Profits Per Employee	-183,614
Employee Count	1
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +222.00% in the last 52 weeks. The beta is 25.16, so Quantumzyme's price volatility has been higher than the market average.

Beta (5Y)	25.16
52-Week Price Change	+222.00%
50-Day Moving Average	2.43
200-Day Moving Average	n/a
Relative Strength Index (RSI)	58.94
Average Volume (20 Days)	40,675

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-158,799
Pretax Income	-183,614
Net Income	-183,614
EBITDA	n/a
EBIT	-158,799
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

The company has 184 in cash and 268,594 in debt, with a net cash position of -268,410 or -0.01 per share.

Cash & Cash Equivalents	184
Total Debt	268,594
Net Cash	-268,410
Net Cash Per Share	-0.01
Equity (Book Value)	-490,585
Book Value Per Share	-0.01
Working Capital	-490,585

Full Balance Sheet

Cash Flow

Operating Cash Flow	-110,037
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Quantumzyme does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.15%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 23, 2023. It was a reverse split with a ratio of 0.01.

Last Split Date	May 23, 2023
Split Type	Reverse
Split Ratio	0.01

Scores

Altman Z-Score	n/a
Piotroski F-Score	1